Currently out of the existing stock ratings of Robert Jones, 31 are a HOLD (34.07%), 7 are a SELL (7.69%), 53 are a BUY (58.24%).

Robert Jones

Work Performance Price Targets & Ratings Chart

Analyst Robert Jones, carries an average stock price target met ratio of 87.44% that have a potential upside of 22.08% achieved within 400 days. Previously, Robert Jones worked at BMO.

Robert Jones’s has documented 191 price targets and ratings displayed on 26 stocks. The coverage was on the Healthcare sector.

Most recent stock forecast was given on ALGN, Align Technology at 26-Oct-2023.

Wall Street Analyst Robert Jones

Analyst best performing recommendations are on ANTM (ANTHEM).
The best stock recommendation documented was for XRAY (DENTSPLY SIRONA) at 4/7/2020. The price target of $40 was fulfilled within 2 days with a profit of $2.81 (7.56%) receiving and performance score of 37.78.

Average potential price target upside

ABC AmerisourceBergen ALGN Align Technology CRL Charles River Laboratories CVS CVS Health Corp EVH Evolent Health MCK McKesson RAD Rite Aid WBA Walgreens Boots Alliance ANTM Anthem CAH Cardinal Health ELV Elevance Health SYNH Syneos Health XRAY Dentsply Sirona UNH UnitedHealth Group ACCD Accolade  CHNG Change Healthcare HSIC Henry Schein ICLR ICON PLC IQV IQVIA Holdings LVGO Livongo Health MDRX Allscripts Healthcare Solutions OSH Oak Street Health PRAH PRA Health Sciences Q Quintiles Transnational HCAT Health Catalyst HQY HealthEquity

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy

$215

$40.04 (22.89%)

$187

2 years 2 months 4 days ago
(06-Aug-2023)

13/14 (92.86%)

$28.91 (15.54%)

633

Hold

$190

$15.04 (8.60%)

$176

2 years 2 months 8 days ago
(02-Aug-2023)

8/8 (100%)

$-0.86 (-0.45%)

433

Buy

$220

$45.04 (25.74%)

$213

2 years 2 months 8 days ago
(02-Aug-2023)

11/17 (64.71%)

$29.14 (15.27%)

326

Buy

$215

$40.04 (22.89%)

$200

2 years 2 months 8 days ago
(02-Aug-2023)

6/8 (75%)

$24.14 (12.65%)

220

Buy

$225

$50.04 (28.60%)

$184

2 years 2 months 10 days ago
(31-Jul-2023)

11/12 (91.67%)

$36.39 (19.29%)

557

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What Year was the first public recommendation made by Robert Jones?

On 2012

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?